RESUMEN
INTRODUCTION: Laser surgery of the larynx is currently the standard of clinical practice in a multitude of procedures. Lasers with photoangiolytic properties have a wide application in endolaryngeal lesions. One of their most prominent features is the ability to coagulate blood vessels, reducing unwanted tissue damage. Our objective is to expose the uses of the blue laser (445 nm) in the larynx. MATERIAL AND METHODS: A retrospective study was carried out including 47 patients treated with blue photoangiolytic laser from October 2021 to January 2023 at a university hospital. Demographic data, type of lesion presented, date of intervention and scope of the procedure, as well as the parameters of the laser used, were recorded. The number of sessions received per patient, the result and complications were also collected. RESULTS: A total of 47 patients with laryngeal lesions were treated, including vascular angiomas, laryngeal sulcus vocali, vocal cord polyps, Reinke's edemas, laryngeal papillomatoses, subglottic stenosis, laryngeal synechiae, subglottic granulomas, glottic scars, vocal fold leukoplakias, laryngeal dysplasias and tracheostomal granulomas. The mean age was 52.5 years, and 64.3% of the patients were women. The range of power used in the resective surgeries was 2-10 Watts with a 20-millisecond window. The average number of sessions received was 2.1 (range 1-4). A satisfactory situation was obtained in 45 of the 47 patients treated (95.75%), and an evident decrease in lesions was seen in the remaining two. There was no evidence of any complications directly derived from the use of the blue laser. Twenty-seven cases (54%) were treated exclusively in-office. CONCLUSIONS: The blue laser is safe and effective in the treatment of a wide range of laryngeal pathologies. Its advantages include its portability, its photoangiolytic qualities as well as its ability to vaporize tissue in contact mode, which can treat subepithelial vessels or resect lesions.
RESUMEN
Many of the patients with COVID-19 have suffered respiratory distress requiring prolonged endotracheal intubation (ETI) resulting in laryngotracheal complication with an impact on breathing, phonation, and swallowing. Our aim is to describe laryngeal injuries diagnosed after ETI in patients with COVID-19 in a multicentre study. METHODS: A prospective descriptive observational study was conducted from January 2021 to December 2021, including COVID-19 patients with laryngeal complications due to ETI diagnosed in several Spanish hospitals. We analyzed the epidemiological data, previous comorbidities, mean time to ICU admission and ETI, need for tracheostomy, mean time on invasive mechanical ventilation until tracheostomy or weaning, mean time in ICU, type of residual lesions, and their treatment. RESULTS: We obtained the collaboration of nine hospitals during the months of January 2021 to December 2021. A total of 49 patients were referred. Tracheostomy was performed in 44.9%, being late in most cases (more than 7-10 days). The mean number of days of ETI until extubation was 17.63 days, and the main post-intubation symptoms were dysphonia, dyspnea, and dysphagia, in 87.8%, 34.7%, and 42.9%, respectively. The most frequent injury was altered laryngeal mobility, present in 79.6%. Statistically, there is a greater amount of stenosis after late ETI and after delayed tracheostomy, not observing the data with the immobility alterations. CONCLUSION: The mean number of days of ETI was long, according to the latest guidelines, with the need for several cycles of pronation. This long ETI may have had an impact on the increase of subsequent laryngeal sequelae, such as altered laryngeal mobility or stenosis.
RESUMEN
INTRODUCTION: The main objective of this study is to estimate the prevalence of persistent dysphonia in hospitalised COVID-19 patients. METHODS: Data were collected from those COVID-19 patients who, during the months of March to April 2020, were hospitalised in ward or intensive care unit at the University Hospital of Fuenlabrada. Patients with dysphonia prior to SARS-CoV-2 were excluded. Informed consent was obtained orally by a telephone call, as well as clinical and epidemiological data. Patients who reported persistent dysphonia were assessed using the Voice Handicap Index 10, the maximum phonation time, the s/z ratio and a fibrolaryngoscope examination. Patients who reported persistent dysphagia were assessed with the Eating Assessment Tool 10. RESULTS: A total of 79 patients were included in the study (48 men and 31 women). 10 ICU patients (25%) and 4 ward patients (10,3%) had dysphonia at least 3 months after hospital discharge, but no association was found between ICU admission and the presence of persistent dysphonia (P = 0.139). Persistent dysphonia in patients admitted to the ICU is associated with persistent dysphagia (P = 0.002), also the age of patients with persistent dysphonia is significantly higher than the age of non-dysphonic patients (P = 0.046). The most frequent exploratory finding was vocal cord paresis/paralysis (60.4%). CONCLUSION: This is one of the first studies to show that persistence of dysphonia may be a consequence of COVID-19, so further studies are needed to assess the evolution and prognosis of these patients and the possible association of dysphonia with the severity of the disease.
Asunto(s)
COVID-19 , Trastornos de Deglución , Disfonía , Parálisis de los Pliegues Vocales , Masculino , Humanos , Femenino , Disfonía/diagnóstico , Disfonía/epidemiología , Disfonía/etiología , COVID-19/complicaciones , COVID-19/diagnóstico , COVID-19/epidemiología , Trastornos de Deglución/diagnóstico , Trastornos de Deglución/epidemiología , SARS-CoV-2 , Parálisis de los Pliegues Vocales/diagnósticoRESUMEN
OBJECTIVE: This series evaluates the long-term results of autologous adipose injection (AAI) in patients older than 65 years with presbyphonia. STUDY DESIGN: Retrospective cohort study. SETTING: Academic secondary medical center. METHODS: This was a retrospective study with a minimum follow-up of 12 months. All patients underwent AAI for atrophy of both vocal folds due to presbyphonia. We measured subjective parameters as Voice Handicap Index-10 (VHI-10) or GRBAS scale (grade, roughness, breathiness, asthenia, strain) and objective measures such as maximum phonation time (MPT) or square pixel closure defect. We reviewed the medical records of patients undergoing AAI during the 2011-2018 period. An analysis of the demographic variables of the group was performed, as well as the values of VHI-10, GRBAS, and MPT, and the minimum closure defect measured in square pixels and the number of closed frames in the glottal cycle before and after the intervention. RESULTS: At 12 months, 17 of 18 patients reported subjective and VHI-10 improvement. The mean preoperative VHI-10 (26.7) was significantly higher than the postoperative value (14.4), and the GRBAS scale had a preoperative mean of 8.7 and a postoperative mean of 4.3, both with statistical significance. MPT increased from 7.7 to 12.4 seconds (P < .0001). The minimum closure defect measurements obtained in square pixels changed from 305 to 124, achieving complete closure in 3 patients. The closed phase of the glottal cycle change from 14.3% to 38.2% after the AAI. CONCLUSIONS: AAI improves long-term vocal fold closure, demonstrating utility in patients with presbyphonia.
Asunto(s)
Pliegues Vocales , Calidad de la Voz , Tejido Adiposo , Humanos , Estudios Retrospectivos , Resultado del Tratamiento , Pliegues Vocales/cirugíaRESUMEN
OBJECTIVE: Functional Endoscopic Sinus Surgery (FESS) is the surgery of choice for nasal polyposis and chronic rhinosinusitis. The aim of our study is to assess the influence of this surgery in the acoustic parameters of voice, and their implications in the systems of identification or verification of the speaker through the speech. MATERIAL AND METHODS: A prospective study was performed between January 2017 and June 2017 including two groups of patients: those undergoing FESS, and a control group. Demographic data and GRBAS assessment were statistically analyzed. In addition, a recording of patients' voices was made with a subsequent acoustic analysis and automatic identification of the speaker through machine learning systems, establishing the equal error rate. Samples were taken before surgery, 2 weeks after surgery and 3 months later. RESULTS: After FESS, a significant difference was observed in Grade, Roughness, Breathiness, Asthenia, Strain (GRBAS). Besides, acoustic analysis showed a significance decrease in fundamental frequency (F0), when compared with the control group. For the automatic identification of the speaker through computer systems, we found that the equal error rate is higher in the FESS group. CONCLUSIONS: Results suggest that FESS produce a decrease of F0 and changes in the vocal tract that derive in an increase in the error of recognition of the speaker in FESS patients.
Asunto(s)
Acústica , Endoscopía , Pólipos Nasales/cirugía , Rinitis/cirugía , Sinusitis/cirugía , Medición de la Producción del Habla , Software de Reconocimiento del Habla , Pliegues Vocales/fisiopatología , Calidad de la Voz , Adulto , Enfermedad Crónica , Femenino , Humanos , Aprendizaje Automático , Masculino , Persona de Mediana Edad , Pólipos Nasales/fisiopatología , Reconocimiento de Normas Patrones Automatizadas , Estudios Prospectivos , Rinitis/fisiopatología , Sinusitis/fisiopatología , Espectrografía del Sonido , Factores de Tiempo , Resultado del TratamientoRESUMEN
BACKGROUND: Septoplasty is a surgical technique for the correction of the nasal septum that may alter the vocal tract. The aim of our study is to assess whether this technique modifies nasalance and acoustic parameters, and their clinical implications in voice perception. METHODOLOGY: A prospective study was performed between January 2017 and June 2017 including 2 groups of patients: those undergoing septoplasty, and a control group. Subjective nasality questionnaire, objective nasalance with nasometer, and GRBAS (Grade, Roughness, Breathiness, Asthenia, Strain) assessment were statistically analysed. In addition, a recording of patients' voices was made with a subsequent acoustic analysis. Samples were taken: pre-surgically, 2 weeks after surgery and after 3 months. RESULTS: After septoplasty, a significant difference was observed in GRBAS, nasality questionnaire and nasometer nasalance, when compared with the control group. As for the acoustic analysis, no differences were observed in most parameters (F0, Jitter, Shimmer, HNR, NHR, Formants F1-F3), except for the antiF3 antiformant, which showed significant changes in all the vowels studied. CONCLUSIONS: Septoplasty can produce changes in the vocal tract, with an increase in initial nasalance but with subsequent normalization. Besides, minor changes were found in the acoustic analysis but with no clinical relevance.
Asunto(s)
Obstrucción Nasal/cirugía , Tabique Nasal/cirugía , Calidad de la Voz , Adulto , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Acústica del LenguajeRESUMEN
OBJECTIVES/HYPOTHESIS: We analyzed the results of 10 patients treated by unilateral autologous temporal fascia graft, comparing the pre and post surgery results, as well as the appearance of the wave and the intervals until the re-appearance of it. STUDY DESIGN: Retrospective, clinical case series. METHODS: Subjective and objective evaluation was preoperatively and postoperatively performed, using laryngovideostroboscopy, the Voice Handicap Index-10, GRBAS (grade, roughness, breathiness, asthenia, and strain), harmonics to noise ratio, Jitter, Shimmer, phonatory range, maximum phonation time, and S/Z ratio in all patients. Postoperative visits were scheduled after 1 week, 1 month, at 3 months, and at 6 months after the surgery. RESULTS: After surgery, we found significant differences in the maximum phonation time and the S/Z ratio (P <0.05). Most parameters of GRBAS also improved significantly, both in general and in the subscales, except for Breathiness and Asthenia (P <0.05). There was an average decrease in Voice Handicap Index-10 of 11.2 (P <0.05). At laryngovideostroboscopy, the mucous wave reappeared in all patients treated 1 month after surgery, and increased in amplitude until 6 months postoperative.
Asunto(s)
Cicatriz/cirugía , Disfonía/cirugía , Fascia/trasplante , Mucosa Laríngea/cirugía , Fonación , Pliegues Vocales/cirugía , Calidad de la Voz , Cicatriz/patología , Cicatriz/fisiopatología , Disfonía/patología , Disfonía/fisiopatología , Humanos , Mucosa Laríngea/patología , Mucosa Laríngea/fisiopatología , Recuperación de la Función , Estudios Retrospectivos , Factores de Tiempo , Trasplante Autólogo , Resultado del Tratamiento , Pliegues Vocales/patología , Pliegues Vocales/fisiopatologíaRESUMEN
INTRODUCTION: The vocal fold microflap technique is the ideal to remove benign vocal fold pathology. Our objective is to compare the amplitudes of the mucosal wave before and after the closure of microflap defect with fibrin glue, and when microflap is left to heal by secondary intention. MATERIALS AND METHODS: The present study is a retrospective series, including 32 patients treated by intracordal phonosurgery, with closure of the microflap either with fibrin glue or by healing by secondary intention. They all had both preoperative and 6-month postoperative track records to allow voice analysis, a subjective Voice Handicap Index 10 (VHI-10), and a good image quality strobe. RESULTS: After selecting the patients was found that the mean overall preoperative VHI-10 was 26.6, and improved up to 10.5 after surgery, a statistical differences (P = 0.03). When comparing both groups, with or without fibrin glue, fibrin glue did not improved results in VHI-10. On the contrary, there was a significant difference in the improvement of the open glottal phase after surgery (P = 0.03), showing a much higher improvement when fibrin glue was used. CONCLUSIONS: The use of fibrin glue after a vocal fold microflap for advanced pathology, such as sulcus vocalis in pocket, vergeture, or vocal fold scar, increases the amplitude of the mucosal wave of the vocal folds, but does not improve the VHI-10 results in our cohort of female patients. So far, patient-reported outcome shows that healing by secondary intention continues to provide excellent voice results.
Asunto(s)
Adhesivo de Tejido de Fibrina/administración & dosificación , Glotis/cirugía , Enfermedades de la Laringe/cirugía , Microcirugia/métodos , Mucosa Respiratoria/cirugía , Colgajos Quirúrgicos , Adhesivos Tisulares/administración & dosificación , Pliegues Vocales/cirugía , Adolescente , Adulto , Niño , Evaluación de la Discapacidad , Femenino , Adhesivo de Tejido de Fibrina/efectos adversos , Glotis/diagnóstico por imagen , Glotis/fisiopatología , Humanos , Enfermedades de la Laringe/diagnóstico por imagen , Enfermedades de la Laringe/fisiopatología , Microcirugia/efectos adversos , Persona de Mediana Edad , Fonación , Recuperación de la Función , Mucosa Respiratoria/diagnóstico por imagen , Mucosa Respiratoria/fisiopatología , Estudios Retrospectivos , Estroboscopía , Factores de Tiempo , Adhesivos Tisulares/efectos adversos , Resultado del Tratamiento , Vibración , Pliegues Vocales/diagnóstico por imagen , Pliegues Vocales/fisiopatología , Calidad de la Voz , Cicatrización de Heridas , Adulto JovenRESUMEN
In this study, two different tools developed for the parametric extraction and acoustic analysis of voice samples are compared. The main goal of the paper is to contrast the results obtained using the classical Multi Dimensional Voice Program (MDVP), with the results obtained with the novel WPCVox. The aim of this comparison was to find differences and similarities in the parameters extracted with both systems in order to make comparison of measurements and data transfer among both equipments. The study was carried out in two stages: in the first, a wide sample of healthy voices belonging to Spanish-speaking adults from both genders were used to carry out a direct comparison between the results given by MDVP and those obtained with WPCVox. In the second stage, a sample of 200 speakers (53 normal and 173 pathological) taken from a commercially available database of voice disorders were used to demonstrate the usefulness of WPCVox for the acoustic analysis and the characterization of normal and pathological voices. The results conclude that WPCVox provides very reliable measurements which are very similar to those obtained using MDVP, and very similar capabilities to discriminate among normal and pathological voices.